NovaSeq PE150 sequencing services

PRE-SOLICITATION NOTICE NOI-NIAID-2085810 NAICS - 541380 This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Novogene Corporation Inc to procure ongoing NovaSeq PE150 sequencing services. This requirement is to send 100 samples of RNA from single cells from cell culture and mouse tissue that are Ehrlichia-infected and uninfected controls single cell RNA-sequencing to evaluate the transcriptional profile of arthropod cells infected with Ehrlichia and the cutaneous immune response during tick transmission of Ehrlichia. This study is a continuation of two other studies, one already conducted for this lab and one conducted for a collaborating lab by Novogene Corp, and the results of all studies must be comparing and analyzed upon completion. The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-2085810 to Dana Monroe at contact@example.gov, by 5:00 pm eastern standard time Monday, September 6, 2021. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.